AI

The AI-powered cardiovascular ultrasound device reportedly offers enhanced spatial and contrast resolution as well as bolstered 4D imaging that enables improved evaluation of cardiac function for a wide range of patients.

Combining advances in imaging quality with access to 26 FDA-cleared applications for automated and accelerated tasks, the Transcend Plus software will be featured at the upcoming European Society of Cardiology (ESC) and American Society of Echocardiography (ASE) conferences.

Catch up on the most-well viewed prostate imaging content in August 2025.

While the research reveals key benefits with portable imaging, particularly point-of-care ultrasound applications with AI capabilities, these authors note challenges with variability in training and advocate for radiologist-led oversight.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

The MyLab A50 and MyLab A70 ultrasound platforms reportedly enable a variety of detailed and multiparametric evaluations, including assessments for liver elastography and strain analysis echocardiography.

Use of the AI-powered Salix Coronary Plaque module, which offers detection of high-risk plaque within 10 minutes based off of CCTA scans, will reportedly qualify for $950 in Category 1 CPT reimbursement in 2026.

A model combining deep learning features and clinical variables demonstrated a 30 percent higher AUC than a clinical model for detecting DCIS and invasive ductal carcinoma from suspicious microcalcifications on mammography, according to a new study.

Over 26 percent of AI-detected future breast cancers and interval breast cancers missed by radiologists were invasive cancers, according to newly published research involving over 42,000 women who had 2D screening mammography.

Reportedly the only point-of-care ultrasound system that can estimate liver stiffness and attenuation that correlate to MRI-PDFF, Velacur One also may facilitate higher reimbursement than non-imaging elastography.

Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.

Catch up on the top radiology content of the past week.

A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.

While a CT-based deep learning model demonstrated a 91 percent AUC for predicting lung cancer risk within one year, researchers noted other mixed results in a new study involving over 18,000 individuals.

Combining sub-second load times and AI-automated features, the PET/CT Viewer Mode and Mammography Viewer Mode may help address bottlenecks in nuclear medicine imaging and mammography workflows.

Offering an 87 percent sensitivity for clinically significant prostate cancer (csPCa), the deep learning model demonstrated an 86 percent AUC for predicting > PI-RADS 3 lesions on prostate MRI.

Catch up on the top radiology content of the past week.

The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.

In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.

Catch up on the top AI-related news and research in radiology over the past month.

The newly launched Definium Pace Select ET X-ray platform reportedly provides increased automation and advanced image processing.

Catch up on the latest MRI studies, AI innovations, and expert insights on abbreviated breast MRI with our Weekly Scan.

The use of adjunctive bpMRI-based AI led to 10 percent and greater increases in lesion-level PPV for csPCa and PCa with a threshold of PI-RADS > 3.

The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.